Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector

被引:0
作者
C Hiller
S Wittmann
S Slavin
H Fickenscher
机构
[1] Institut für Klinische und Molekulare Virologie,Department of Bone Marrow Transplantation
[2] Friedrich-Alexander-Universität Erlangen-Nürnberg,undefined
[3] Hadassah University Hospital,undefined
来源
Gene Therapy | 2000年 / 7卷
关键词
herpesvirus saimiri; adoptive immunotherapy; T lymphocytes; ganciclovir; thymidine kinase; Cre recombinase;
D O I
暂无
中图分类号
学科分类号
摘要
Herpesvirus saimiri transforms human T lymphocytes to stable growth and persists episomally without genomic integration and without virus production. The transformed T cells retain essential features of their parental cells including the MHC-restricted antigen specificity which may be useful for applications in adoptive immunotherapy. In order to improve the biological safety of such vectors, the prodrug activating gene thymidine kinase of herpes simplex virus was inserted into the genome of herpesvirus saimiri by homologous recombination. After infection with wild-type or cloned recombinant viruses, T cells from tamarin monkeys and from humans were transformed to stable growth. Thymidine kinase-expressing transformed T cells were efficiently eliminated in the presence of low concentrations of ganciclovir. This elimination mechanism remained fully functional over an observation period of 12 months. The potentially immunogenic neomycin resistance gene expression cassette was deleted from the genome of established mutant viruses by using the prokaryotic Cre/LoxP recombination system. At any time during the course of a therapeutic application, thymidine kinase-expressing transformed human T cells might be eliminated after administration of ganciclovir. In principle, this function could be useful for the T cell-dependent immunotherapy of resistant blood cancer while avoiding the risk of uncontrolled graft-versus-host disease.
引用
收藏
页码:664 / 674
页数:10
相关论文
共 99 条
[1]  
Riddell SR(1995)Principles for adotive T cell therapy of human viral diseases Annu Rev Immunol 13 545-586
[2]  
Greenberg PD(1997)Adoptive immunotherapy with donor lymphocyte transfusions Curr Opin Oncol 9 139-145
[3]  
Kolb HJ(1992)Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones Science 257 238-241
[4]  
Holler E(1995)Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor New Engl J Med 333 1038-1044
[5]  
Riddell SR(1997)HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 276 1719-1724
[6]  
Walter EA(1996)Long-term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nature Med 2 551-555
[7]  
Bonini C(1994)Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl J Med 330 1185-1191
[8]  
Heslop HE(1995)Use of gene-modified virus-specific T lymphocytes to control Epstein–Barr-virus-related lymphoproliferation Lancet 345 9-14
[9]  
Papadopoulos EB(1997)Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 15 433-444
[10]  
Rooney CM(1990)Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 2462-2465